AbbVie ile ilgili hikayeler

• Bayer said it is shifting the focus of its pharmaceutical business to the US and away from Europe and the UK, reported the Financial Times, where countries are making "big mistakes" and becoming "innovation unfriendly" because policymakers were making it more difficult to generate commercial returns on their investments. via FT On a related note: US drugmakers AbbVie and Eli Lilly became the first pharmaceutical groups to pull out of a pricing agreement wi...Devamını Oku

17 Oca 2023